G
Ginkgo Bioworks
Automated cell programming and biological engineering platform.
At a glance
- Founded
- 2008
- Headquarters
- Boston, United States
- Listing
- Public via SPAC 2021
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
News
Terra Genomics raises $3.3M seed to engineer microbes for farm biologicals
Sep 1, 2026
News
Transfyr launches with $25M seed to close science's physical-to-digital gap
Aug 27, 2026
Market map
US Advanced Materials Startups
Jun 25, 2026
News
Ayana Bio and Brevel net $1.25M BIRD grant to test illuminated fermentation for plant cell culture
Jun 4, 2026
Market map
Molecular farming
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Y Combinator- FNFarzad (Zod) Nazem
TSVC
Hari Raghavan
Series A7 investors entered at this stage
- IMIan McNish
Felicis
Justin Kan
Vast Ventures- OFOS Fund
David Beyer- IPiGlobe Partners
Series B and later14 investors entered at this stage
Allen & Company- SVStarling Ventures
General Atlantic- 1C11.2 Capital
Baillie Gifford- MTMassachusetts Institute of Technology
- CICascade Investment
Illumina- DADARPA
- VIViking Global Investors
T. Rowe Price
MicroVentures- BGBill Gates
- SGSenator Investment Group
Source: Dealroom Talent Intelligence.
Alumni founders
Former Ginkgo Bioworks employees who went on to found companies, sorted by Dealroom signal score.
Effendi LeonardUnited States
JBJoyn BioEst. 2018
Brynne StantonUnited States
OBOctant BioEst. 2017
Sri KosuriUnited StatesGlobal footprint
across markets
Patents
252 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Ginkgo Bioworks was the backer or acquirer, 2017–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
19 deals across Ginkgo Bioworks's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Ginkgo Bioworks deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Ginkgo Bioworks's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ginkgo Bioworks on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ginkgo Bioworks on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.